DrugDashboards

Testosterone Cypionate

Testosterone Cypionate · TESTOSTERONE CYPIONATE 200 mg/mL · Injection, Solution · Intramuscular · Bryant Ranch Prepack

NDC 71335-2470-01 · 1 VIAL, GLASS in 1 CARTON / 1 mL in 1 VIAL, GLASS · ANDA · View full market →

The short version

18 companies supply this market — deep enough that no single failure threatens the supply. Historically, drugs in this position went on to a new shortage within 90 days about 0.5% of the time — roughly 3× the typical drug (0.1%).

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

All Part D pricing →

Matched to CMS's representative package for this drug (NDC 00009-0417-01) — same generic, strength, and dosage form. CMS prices one NDC per drug concept, not every package.

ⓘ How this was built
Data sources
  • CMS quarterly Prescription Drug Plan Formulary & Pricing files (SPUF)
Method

Negotiated 30-day point-of-sale unit prices and formulary terms aggregated across every unsuppressed Part D and MA-PD plan for the quarter shown. Point of sale means gross of confidential rebates. CMS publishes one representative NDC per drug concept (RxCUI) rather than every package, so these figures come from CMS's representative package for the same drug — matched on generic name, strength, and dosage form. Estimated from MedPAC's program-wide rebate aggregates (June 2023: DIR = 29% of gross Part D spending; brand rebates ≈ 25–40% of gross, generics minimal). Actual rebates are confidential and vary widely by drug — this is a range, not a fact about this drug.

Pipeline and calculations built by Claude (Fable 5) from the public datasets above. Educational only — verify against primary sources before acting.

Plans pay at point of saleⓘ
$12.85per unit
middle half $7.29–$12.89 · 1,424 plans · Apr 1, 2026
Est. net of rebatesⓘ
≈ $12.85
generic — rebates are minimal, so net ≈ gross
Coverage & restrictions
26%of plans cover it
tier 3 · prior auth 62% · step therapy 0% · qty limit 0%

*No drug-level rebate is public — the estimate applies MedPAC's program-wide brand rebate range to this drug's gross price. Tracked here for 10 quarters since 2024.

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.5%chance of a new FDA shortage posting for testosterone cypionate (injectable) in the next 90 days

sterile injectable · OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is 3× that.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill · avg $37.01 per prescription
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA040530
TE code
AO
Approval date
Jan 31, 2005
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Testosterone Cypionate (Injection, Solution)

LabelerStrengthFirst seenLast seen
Asclemed USA, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Azurity Pharmaceuticals, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Bryant Ranch PrepackTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Pharmacia & Upjohn Company LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Xiromed LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 3, 2026
Alvogen Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Asclemed Usa Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 22, 2026Sep 2, 2026
Asclemed USA, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Cipla USA Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 2000 mg/10mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCTESTOSTERONE CYPIONATE 1000 mg/10mLJul 15, 2026Sep 2, 2026
Hospira, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Hospira, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
LSNE, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NorthStar Rx LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
NuCare Pharmaceuticals,Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Sep 2, 2026
Pharmacia & Upjohn Company LLCTESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Steroid S.p.A.TESTOSTERONE CYPIONATE 25000 g/25000gJul 15, 2026Sep 2, 2026
Sun Pharmaceutical Industries, Inc.TESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
Xiromed LLCTESTOSTERONE CYPIONATE 100 mg/mLJul 15, 2026Sep 2, 2026
A-S Medication SolutionsTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
Padagis US LLCTESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
Sun Pharmaceutical Industries, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Aug 31, 2026
American Regent, Inc.TESTOSTERONE CYPIONATE 200 mg/mLJul 15, 2026Jul 29, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Testosterone Cypionate — NDC 71335-2470-01," retrieved September 3, 2026, https://drugdashboards.com/drug/71335247001.

Free to cite with attribution — see how the data is put together.